Immune-mediated mechanisms of tumor development may be particularly relevant to BRCA1-driven neoplasms, as BRCA1 inactivation is associated with a deficiency in homologous DNA repair, chromosomal instability, and, consequently, increased tumor antigenicity [15,16,17]. Here, BRCA1 is linked to neoplasm.